My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Yes Bank commits to NHAIs Adopt Green Highway program
Nov 23,2016

Yes Bank has become the first private sector player into a Corporate Social Responsibility commitment with the National Highways Authority under its Adopt Green Highway program. Through this partnership, Yes Bank is committed to developing green corridors along Mumbai-Nashik-Pimpalgaon Highway.

Powered by Capital Market - Live News

Board of Prestige Estates Projects to consider September quarter and half year results
Nov 23,2016

Prestige Estates Projects announced that a Meeting of the Board of Directors of the Company is scheduled to be held on 07 December 2016, inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended 30 September 2016.

Powered by Capital Market - Live News

SREI Infrastructure Finance appoints CEO
Nov 23,2016

SREI Infrastructure Finance announced the appointment of Sameer Sawhney as Chief Executive Officer, effective 05 November 2016.

Powered by Capital Market - Live News

JBF Industries weaves strong gains after stellar Q2 results
Nov 23,2016

The result was announced after market hours yesterday, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 2.79 points, or 0.01%, to 25,963.57

On BSE, so far 16,000 shares were traded in the counter, compared with average daily volume of 29,882 shares in the past one quarter. The stock hit a high of Rs 211.40 and a low of Rs 199 so far during the day. The stock hit a 52-week high of Rs 260.10 on 18 October 2016. The stock hit a 52-week low of Rs 150.10 on 29 February 2016. The stock had underperformed the market over the past 30 days till 22 November 2016, sliding 20.22% compared with the 7.87% decline in the Sensex. The scrip, however, outperformed the market in past one quarter, falling 6.56% as against Sensexs 7.48% decline.

The small-cap company has an equity capital of Rs 81.87 crore. Face value per share is Rs 10.

JBF Industries produces polyester chips for textiles, films and bottles and partially oriented yarn.

Powered by Capital Market - Live News

Board of Reliance Chemotex Industries to approve change in CFO
Nov 23,2016

Reliance Chemotex Industries announced that a Meeting of Board of Directors of the Company will be held on 30 November 2016 to take note on resignation of Ravindra Kala, Chief Financial Officer and to consider and appoint Kiran Firodiya, as Chief Financial Officer (KMP).

Powered by Capital Market - Live News

Tentiwala Metal Products to announce September half year results
Nov 23,2016

Tentiwala Metal Products announced that the meeting of Board of Directors will be held on 30 November 2016, to consider, approve and to take on record Un-Audited Financial Results for the half-year ended on 30 September 2016.

Powered by Capital Market - Live News

EPC Industrie allots equity shares
Nov 23,2016

EPC Industrie announced that the Nomination and Remuneration Committee of Directors on 22 November 2016 has allotted 11,877 Equity Shares of Rs. 10 each respectively to the Employees of the Company who have exercised their Stock Options under the Companys Employee Stock Option Scheme, 2014.

Post allotment, the Paid up capital of the Company stands increased to 2,76,70,349 Shares of Rs. 10 each aggregating to Rs. 27,67,03,490/- (Rupees Twenty Seven Crores Sixty Seven lacs Three Thousand Four Hundred Ninety only).

Further, the Committee has also granted new 1,33,432 Stock Options to employees.

Powered by Capital Market - Live News

Bhagyanagar India intimates of High Court sanction for scheme of arrangement
Nov 23,2016

Bhagyanagar India announced that the Honble High Court of Hyderabad has sanctioned the scheme of arrangement on 21 November 2016 between Bhagyanagar India (demerged company) and Surana Telecom and Power (1st results company) and Bhagyanagar Properties (2nd resulting company) and their respectively shareholders and creditors.

Powered by Capital Market - Live News

Sun Pharmaceutical Industries announces resignation of CFO
Nov 23,2016

Sun Pharmaceutical Industries announced that the Company have received a letter intimating to the Company from the Companys Chief Financial Officer (CFO), Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries to be effective with effect from in and around April, 2017 due to his shifting to United States of America in and around April, 2017 to look after the business of Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical Industries as its Chief Executive Officer.

Powered by Capital Market - Live News

Sun Pharma gains after acquisition in Russia
Nov 23,2016

The announcement was made before trading hours today, 23 November 2016.

Meanwhile, the BSE Sensex was up 4.56 points, or 0.02%, to 25,965.34.

On BSE, so far 48,000 shares were traded in the counter, compared with average daily volume of 3.49 lakh shares in the past one quarter. The stock hit a high of Rs 696.65 and a low of Rs 691.55 so far during the day. The stock hit a 52-week high of Rs 898 on 23 February 2016. The stock hit a 52-week low of Rs 572.40 on 9 November 2016. The stock had outperformed the market over the past 30 days till 22 November 2016, falling 7.68% compared with the 7.87% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.50% as against Sensexs 7.48% decline.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Re 1.

Sun Pharmaceutical Industries (Sun Pharma) announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region. The equity consideration for the 85.1% stake is $24 million. Sun Pharma would also assume a debt of approximately $36 million as part of this transaction. Biosintez is a Russian pharmaceutical company focusing on the hospital segment with annual revenues of approximately $52 million for 2015. It has a manufacturing facility in Penza region with capabilities to manufacture a wide variety of dosage forms including pharmaceuticals for injections, blood substitutes, blood preservatives, ampoules, tablets, ointment, creams, gels, suppositories, active pharmaceutical ingredients (APIs), etc.

The transaction, expected to be completed by end of 2016, is subject to approval of the Russian Federal AntiMonopoly Service and other closing conditions. As per IMS (MAT September 2016), the Russian pharmaceutical market recorded sales of approximately $10 billion. The market recorded a growth of 7.4% in local currency terms as per IMS.

In a separate announcement after market hours yesterday, 22 November 2016, Sun Pharma said it received a letter from the Chief Financial Officer (CFO), Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries to be effective with effect from in and around April 2017 due to his shifting to United States of America in and around April 2017 to look after the business of Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical Industries as its Chief Executive Officer.

On a consolidated basis, Sun Pharmaceutical Industries net profit surged 117.25% to Rs 2235.14 crore on 13.21% rise in net sales to Rs 7764.03 crore in Q2 September 2016 over Q2 September 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Surana Telecom and Power gets High Court approval for scheme of arrangement
Nov 23,2016

Surana Telecom and Power announced that the Honble High Court of Hyderabad has sanctioned the scheme of arrangement between Bhagyanagar India (demerged company) and Surana Telecom and Power (1st results company) and Bhagyanagar Properties (2nd resulting company) and their respectively shareholders and creditors.

Powered by Capital Market - Live News

Bharti Airtel gains after completing acquisition of rights to use spectrum for AP circle
Nov 23,2016

The announcement was made after market hours yesterday, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 55.66 points or 0.21% at 26,016.44

On BSE, so far 15,000 shares were traded in the counter as against average daily volume of 3.14 lakh shares in the past one quarter. The stock hit a high of Rs 308 and a low of Rs 304 so far during the day. The stock had hit a 52-week high of Rs 384.90 on 28 April 2016. The stock had hit a 52-week low of Rs 282.30 on 29 January 2016. The stock had outperformed the market over the past 30 days till 22 November 2016, falling 0.8% compared with the 7.87% decline in the Sensex. The scrip, however, underrperformed the market in past one quarter, sliding 13.77% as against Sensexs 7.48% decline.

The large-cap company has equity capital of Rs 1998.70 crore. Face value per share is Rs 5.

Bharti Airtel announced that it has successfully completed the acquisition of rights to use 20 MHz of spectrum in 2300 Band ( BWA) from Aircel, for Andhra Pradesh circle following the receipt of all necessary approvals and satisfying all the conditions (including conditions stated in the Spectrum Trading Guidelines). With this, Bharti Airtel has completed the transaction in all 8 telecom circles, the company said.

On a consolidated basis, Bharti Airtels net profit fell 4.9% to Rs 1460.70 crore on 3.4% growth in net sales to Rs 24651.50 crore in Q2 September 2016 over Q2 September 2015.

Bharti Airtel is a leading global telecommunications company with operations in 18 countries across Asia and Africa.

Powered by Capital Market - Live News

EIH to delist GDRs from London Stock Exchange
Nov 23,2016

EIH announced that the Company has terminated the Depository Agreement with Bank of New York Mellon (Depositary), resulting in termination of GDR facility. The Company will delist its GDRs from the London Stock Exchange.

The termination of the deposit agreement is expected to occur on or about 23 February 2017and the listing and admission to trading of the GDRs on the London Stock Exchange will be cancelled with effect from the same date.

Powered by Capital Market - Live News

Jammu and Kashmir Bank announces change in company secretary
Nov 23,2016

Jammu and Kashmir Bank announced that Mohammad Shafi Mir, FCS shall act as Company Secretary and Compliance officer of the Bank with immediate effect in place of Abdul Majid Bhat.

Powered by Capital Market - Live News

Shares of Unipro Technologies get listed
Nov 23,2016

The equity shares of Unipro Technologies (Scrip Code: 540189) are listed effective 23 November 2016 and admitted to dealings on the Exchange in the list of XT Group Securities

Powered by Capital Market - Live News